National Vaccine And Serum Institute, China

This large phase 3 trial tested a new norovirus vaccine in 8,000 healthy children aged 6 months to 13 years. The vaccine targets two common norovirus strains (GⅠ.1 and GⅡ.4) that cause severe vomiting and diarrhea. Researchers compared vaccinated kids to those who got a placebo t…

This study tested a new recombinant COVID-19 vaccine (made using CHO cells) in healthy people aged 3 and older. The trial involved 3,100 participants across two phases to check safety, side effects, and immune response. Participants received either a low or high dose of the vacci…

This early-stage trial tested a new recombinant COVID-19 vaccine (GEN2) in 234 healthy adults aged 18 and older. The main goal was to check safety and how well the body's immune system responds. Participants received one of three different doses or a placebo, and researchers moni…